Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuralgia × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 103 Neoplasms, Plasma Cell 31 Neoplasms 12 Brain Neoplasms 12 Recurrence 11 Central Nervous System Neoplasms 11 Glioblastoma 10 Carcinoma, Hepatocellular 10 Melanoma 9 Prostatic Neoplasms 8 Leukemia 8 Gliosarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 7 Waldenstrom Macroglobulinemia 6 Lung Neoplasms 6 Glioma 6 Sarcoma 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Colorectal Neoplasms 5 Myelodysplastic Syndromes 4 Lymphoma 4 Colonic Neoplasms 4 Astrocytoma 4 Rectal Neoplasms 3 Oligodendroglioma 3 Neuroblastoma 3

Interventions

Pregabalin 4 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 onabotulinum toxin A 1 nabiximols 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Sodium Chloride 1 Saline Solution 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1 Low-Level Light Therapy 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hydromorphone 1 Hospitals 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00284505 2008-12-05

Use of Thalidomide in Patients With Arachnoiditis

Washington University School of Medicine

Phase 2 Completed

Arachnoiditis, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡